A cancer drug already on the market might be a game-changer for Parkinson’s! Scientists found that nivolumab–relatlimab (yep, the melanoma treatment) can block the spread of those nasty protein clumps that wreck movement and speech in Parkinson’s. In mice, it kept their brains and motor skills in way better shape. Since this drug’s already FDA-approved for cancer, it could speed up Parkinson’s trials. Imagine if one medicine could slow two major diseases! #Health #BodyHealth #Parkinsons